haloperidol has been researched along with jl 13 compound in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruhwyler, J; Cools, AR; Ellenbroek, BA; LiƩgeois, JF | 1 |
Bruhwyler, J; Damas, J; Delarge, J; Hendrick, JC; Legros, JJ; LiƩgeois, JF | 1 |
2 other study(ies) available for haloperidol and jl 13 compound
Article | Year |
---|---|
Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepinones; Central Nervous System Stimulants; Clozapine; Disease Models, Animal; Drug Evaluation, Preclinical; Haloperidol; Locomotion; Male; Pyridines; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia | 2001 |
Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Hyperprolactinemia; Male; Pituitary Gland, Anterior; Prolactin; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2002 |